☰

Jiesi Luo - Publications

Affiliations: 
Yale University, New Haven, CT 
Area:
stem cell and cardiology
Tree Info Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Ji J, Xu H, Li C, Luo J. Small-Caliber Tissue Engineered Vascular Grafts based on Human iPS Cells: Progress and Challenges. Tissue Engineering. Part B, Reviews. PMID 36884294 DOI: 10.1089/ten.TEB.2023.0005  0.457
2022 Luo J, Qin L, Park J, Kural MH, Huang Y, Shi X, Riaz M, Wang J, Ellis MW, Anderson CW, Yuan Y, Ren Y, Yoder MC, Tellides G, Niklason LE, et al. Readily Available Tissue-Engineered Vascular Grafts Derived From Human Induced Pluripotent Stem Cells. Circulation Research. CIRCRESAHA121320315. PMID 35189711 DOI: 10.1161/CIRCRESAHA.121.320315  0.458
2022 Li ML, Luo J, Ellis MW, Riaz M, Ajaj Y, Qyang Y. Methods for Differentiating hiPSCs into Vascular Smooth Muscle Cells. Methods in Molecular Biology (Clifton, N.J.). 2375: 21-34. PMID 34591296 DOI: 10.1007/978-1-0716-1708-3_3  0.422
2021 Ellis MW, Riaz M, Huang Y, Anderson CW, Luo J, Park J, Lopez CA, Batty LD, Gibson KH, Qyang Y. Epigallocatechin gallate facilitates extracellular elastin fiber formation in induced pluripotent stem cell derived vascular smooth muscle cells for tissue engineering. Journal of Molecular and Cellular Cardiology. PMID 34979103 DOI: 10.1016/j.yjmcc.2021.12.014  0.447
2021 Gao X, Gao M, Gorecka J, Langford J, Liu J, Luo J, Taniguchi R, Matsubara Y, Liu H, Guo L, Gu Y, Qyang Y, Dardik A. Human-Induced Pluripotent Stem-Cell-Derived Smooth Muscle Cells Increase Angiogenesis to Treat Hindlimb Ischemia. Cells. 10. PMID 33918299 DOI: 10.3390/cells10040792  0.411
2021 Tang WY, Liu JH, Peng CJ, Liao Y, Luo JS, Sun X, Tang YL, Luo XQ. Functional Characteristics and Application of Mesenchymal Stem Cells in Systemic Lupus Erythematosus. Archivum Immunologiae Et Therapiae Experimentalis. 69: 7. PMID 33713197 DOI: 10.1007/s00005-021-00603-y  0.312
2020 Shi X, He L, Zhang SM, Luo J. Human iPS Cell-derived Tissue Engineered Vascular Graft: Recent Advances and Future Directions. Stem Cell Reviews and Reports. PMID 33230612 DOI: 10.1007/s12015-020-10091-w  0.469
2020 Luo J, Shi X, Lin Y, Yuan Y, Kural MH, Wang J, Ellis MW, Anderson CW, Zhang SM, Riaz M, Niklason LE, Qyang Y. Efficient Differentiation of Human Induced Pluripotent Stem Cells into Endothelial Cells under Xenogeneic-free Conditions for Vascular Tissue Engineering. Acta Biomaterialia. PMID 33166710 DOI: 10.1016/j.actbio.2020.11.007  0.427
2020 Luo J, Lin Y, Shi X, Li G, Kural MH, Anderson CW, Ellis MW, Riaz M, Tellides G, Niklason LE, Qyang Y. Xenogeneic-free generation of vascular smooth muscle cells from human induced pluripotent stem cells for vascular tissue engineering. Acta Biomaterialia. PMID 33130306 DOI: 10.1016/j.actbio.2020.10.042  0.489
2020 Gorecka J, Gao X, Fereydooni A, Dash BC, Luo J, Lee SR, Taniguchi R, Hsia HC, Qyang Y, Dardik A. Induced pluripotent stem cell-derived smooth muscle cells increase angiogenesis and accelerate diabetic wound healing. Regenerative Medicine. PMID 32228292 DOI: 10.2217/Rme-2019-0086  0.401
2020 Luo J, Qin L, Zhao L, Gui L, Ellis MW, Huang Y, Kural MH, Clark JA, Ono S, Wang J, Yuan Y, Zhang SM, Cong X, Li G, Riaz M, et al. Tissue-Engineered Vascular Grafts with Advanced Mechanical Strength from Human iPSCs. Cell Stem Cell. PMID 31956039 DOI: 10.1016/J.Stem.2019.12.012  0.489
2019 Cong X, Zhang SM, Batty L, Luo J. Application of Human Induced Pluripotent Stem Cells in Generating Tissue Engineered Blood Vessels as Vascular Grafts. Stem Cells and Development. PMID 31663439 DOI: 10.1089/Scd.2019.0234  0.5
2019 Park J, Anderson CW, Sewanan LR, Kural MH, Huang Y, Luo J, Gui L, Riaz M, Lopez CA, Ng R, Das SK, Wang J, Niklason L, Campbell SG, Qyang Y. Modular Design of a Tissue Engineered Pulsatile Conduit using Human Induced Pluripotent Stem Cell-derived Cardiomyocytes. Acta Biomaterialia. PMID 31634626 DOI: 10.1016/J.Actbio.2019.10.019  0.432
2019 Cong X, Zhang SM, Ellis MW, Luo J. Large Animal Models for the Clinical Application of Human Induced Pluripotent Stem Cells. Stem Cells and Development. PMID 31359827 DOI: 10.1089/Scd.2019.0136  0.423
2019 Gorecka J, Kostiuk V, Fereydooni A, Gonzalez L, Luo J, Dash B, Isaji T, Ono S, Liu S, Lee SR, Xu J, Liu J, Taniguchi R, Yastula B, Hsia HC, et al. The potential and limitations of induced pluripotent stem cells to achieve wound healing. Stem Cell Research & Therapy. 10: 87. PMID 30867069 DOI: 10.1186/S13287-019-1185-1  0.439
2019 Gorecka JR, Fereydooni A, Luo J, Dash B, Isaji T, Gonzalez L, Lee SR, Qyang Y, Hsia H, Dardik A. Induced Pluripotent Stem Cell Derived Smooth Muscle Cells Are Superior to Mesenchymal Stem Cells at Accelerating Diabetic Wound Healing Journal of the American College of Surgeons. 229: S331. DOI: 10.1016/J.Jamcollsurg.2019.08.723  0.44
2018 Ellis MW, Luo J, Qyang Y. Modeling elastin-associated vasculopathy with patient induced pluripotent stem cells and tissue engineering. Cellular and Molecular Life Sciences : Cmls. PMID 30460472 DOI: 10.1007/S00018-018-2969-7  0.497
2017 Luo J, Qin L, Kural MH, Schwan J, Li X, Bartulos O, Cong XQ, Ren Y, Gui L, Li G, Ellis MW, Li P, Kotton DN, Dardik A, Pober JS, et al. Vascular smooth muscle cells derived from inbred swine induced pluripotent stem cells for vascular tissue engineering. Biomaterials. 147: 116-132. PMID 28942128 DOI: 10.1016/J.Biomaterials.2017.09.019  0.505
2017 Anderson CW, Boardman N, Luo J, Park J, Qyang Y. Stem Cells in Cardiovascular Medicine: the Road to Regenerative Therapies. Current Cardiology Reports. 19: 34. PMID 28324469 DOI: 10.1007/S11886-017-0841-2  0.428
2016 Luo J, Cibelli JB. Mechanisms of Pluripotency Maintenance In Canine Pluripotent Stem Cells under bFGF and LIF supplementation. Stem Cells and Development. PMID 27492281 DOI: 10.1089/Scd.2016.0164  0.361
2016 Dash BC, Levi K, Schwan J, Luo J, Bartulos O, Wu H, Qiu C, Yi T, Ren Y, Campbell S, Rolle MW, Qyang Y. Tissue-Engineered Vascular Rings from Human iPSC-Derived Smooth Muscle Cells. Stem Cell Reports. 7: 19-28. PMID 27411102 DOI: 10.1016/J.Stemcr.2016.05.004  0.492
2016 Gui L, Dash BC, Luo J, Qin L, Zhao L, Yamamoto K, Hashimoto T, Wu H, Dardik A, Tellides G, Niklason LE, Qyang Y. Implantable tissue-engineered blood vessels from human induced pluripotent stem cells. Biomaterials. 102: 120-129. PMID 27336184 DOI: 10.1016/J.Biomaterials.2016.06.010  0.496
2016 Misra A, Sheikh AQ, Kumar A, Luo J, Zhang J, Hinton RB, Smoot L, Kaplan P, Urban Z, Qyang Y, Tellides G, Greif DM. Integrin β3 inhibition is a therapeutic strategy for supravalvular aortic stenosis. The Journal of Experimental Medicine. PMID 26858344 DOI: 10.1085/Jgp.1473Oia18  0.311
2015 Chang EA, Tomov ML, Suhr ST, Luo J, Olmsted ZT, Paluh JL, Cibelli J. Derivation of Ethnically Diverse Human Induced Pluripotent Stem Cell Lines. Scientific Reports. 5: 15234. PMID 26482195 DOI: 10.1038/Srep15234  0.322
2011 Luo J, Suhr ST, Chang EA, Wang K, Ross PJ, Nelson LL, Venta PJ, Knott JG, Cibelli JB. Generation of leukemia inhibitory factor and basic fibroblast growth factor-dependent induced pluripotent stem cells from canine adult somatic cells. Stem Cells and Development. 20: 1669-78. PMID 21495906 DOI: 10.1089/Scd.2011.0127  0.376
Show low-probability matches.